Soragni, E., Xu, C., Plasterer, H. L., Jacques, V., Rusche, J. R., & Gottesfeld, J. M. (2012). Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia.

Soragni, Elisabetta, Chunping Xu, Heather L. Plasterer, Vincent Jacques, James R. Rusche, and Joel M. Gottesfeld. Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors As Therapeutics for Friedreich Ataxia. 2012.

Soragni, Elisabetta, et al. Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors As Therapeutics for Friedreich Ataxia. 2012.